IL6 as a mediator of insulin resistance: fat or fiction? T. L. AllenM. A. Febbraio Commentary 10 December 2009 Pages: 399 - 402
Oxidative stress and glucose metabolism—is there a need to revisit effects of insulin treatment? P. M. Humpert Commentary 06 January 2010 Pages: 403 - 405
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective A. E. BuykenP. MitchellJ. Brand-Miller Review 05 January 2010 Pages: 406 - 418
Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study) H. SoneS. Tanakafor the Japan Diabetes Complications Study Group Article Open access 07 January 2010 Pages: 419 - 428
Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study S.-H. LeeB. J. KimB.-W. Yoon Article 29 November 2009 Pages: 429 - 434
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study R. A. DeFronzoM. A. Banerjifor the ACT NOW Study Group Article 10 December 2009 Pages: 435 - 445
Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction A. García-PattersonI. GichR. Corcoy Article 15 December 2009 Pages: 446 - 451
Prediction of postpartum diabetes in women with gestational diabetes mellitus M. EkelundN. ShaatK. Berntorp Article 02 December 2009 Pages: 452 - 457
The gait and balance of patients with diabetes can be improved: a randomised controlled trial L. AlletS. ArmandE. D. de Bruin Article Open access 17 November 2009 Pages: 458 - 466
Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study J. LabadJ. F. Priceon behalf of the Edinburgh Type 2 Diabetes Study Investigators Short Communication 10 December 2009 Pages: 467 - 471
Case fatality rates after first acute coronary syndrome in persons treated for type 2 diabetes show an improving trend K. M. WinellR. PääkkönenV. V. Salomaa Article 09 December 2009 Pages: 472 - 480
Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS) I. MurakiT. Tanigawafor the CIRCS Investigators Article 28 November 2009 Pages: 481 - 488
The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case–control study F.-Y. HsiaoC. D. Mullins Article 27 November 2009 Pages: 489 - 496
Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia D. T. EurichJ. M. GambleS. R. Majumdar Article 20 November 2009 Pages: 497 - 503
The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention K. MüssigM. HeniH. Staiger Article 29 November 2009 Pages: 504 - 509
NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study A. Y. ChuJ. CoreshW. H. L. Kao Article 27 November 2009 Pages: 510 - 516
Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials J. De GrijseM. Asanghanwathe Belgian Diabetes Registry Article 29 November 2009 Pages: 517 - 524
Human IL6 enhances leptin action in mice M. SadagurskiL. NorquayM. F. White Article Open access 10 November 2009 Pages: 525 - 535
Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis B. GustafsonB. EliassonU. Smith Article 27 November 2009 Pages: 536 - 540
Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle K. HøjlundZ. YiL. J. Mandarino Article 12 December 2009 Pages: 541 - 551
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice J. HsiehC. LonguetK. Adeli Article 03 December 2009 Pages: 552 - 561
Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy L. MonnierC. ColetteD. R. Owens Article 05 November 2009 Pages: 562 - 571
A novel primate model of delayed wound healing in diabetes: dysregulation of connective tissue growth factor S. E. ThomsonS. V. McLennanS. M. Twigg Article 29 November 2009 Pages: 572 - 583
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes A. KoïtkaZ. CaoT. J. Allen Article 03 December 2009 Pages: 584 - 592